Given that elevated plasma levels of MMP-2 have been observed in patients with congestive HF, regardless of the underlying cause (such as acute MI, dilated cardiomyopathy, or valvular disease), MMP-2 may serve as a potential biomarker [41]. The gene discussed is MMP2; the disease is dilated cardiomyopathy.